Bioceltix SA (BCX) Financial Statements
Bioceltix SA Financial Overview
Bioceltix SA's market cap is currently $387.26M. The company's EPS TTM is $-3.48; its P/E ratio is -20.11; Bioceltix SA has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Mar 26 | Mar 25 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ -680.06K | $ -574.43K | ― | $ -445.38K | $ -376.98K |
| Operating Income | $ -17.32M | $ -18.83M | $ -15.82M | $ -9.67M | $ -6.21M |
| EBITDA | $ -16.64M | $ -14.04M | $ -13.22M | $ -8.49M | $ -3.95M |
| Net Income | $ -15.16M | $ -14.90M | $ -13.69M | $ -8.92M | $ -4.40M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 68.40M | $ 33.63M | $ 9.31M | $ 4.12M | $ 6.05M |
| Total Assets | $ 75.63M | $ 41.85M | $ 12.74M | $ 5.99M | $ 8.20M |
| Total Debt | $ 314.90K | $ 823.92K | $ 175.06K | $ 293.94K | $ 530.83K |
| Net Debt | $ -68.09M | $ -32.81M | $ -9.14M | $ -3.83M | $ -5.52M |
| Total Liabilities | $ 2.36M | $ 3.44M | $ 2.27M | $ 2.50M | $ 2.20M |
| Stockholders' Equity | $ 73.28M | $ 38.42M | $ 10.47M | $ 5.15M | $ 6.00M |
| Cash Flow | |||||
| Free Cash Flow | $ -14.07M | $ -17.98M | $ -15.21M | $ -8.26M | $ -4.05M |
| Operating Cash Flow | $ -12.10M | $ -17.74M | $ -14.75M | $ -7.91M | $ -4.04M |
| Investing Cash Flow | $ -1.97M | $ -84.24K | $ -458.35K | $ -351.73K | $ 134.06K |
| Financing Cash Flow | $ 48.84M | $ 42.14M | $ 20.40M | $ 6.32M | $ 6.76M |
Currency in PLN
